CoChat

The Incorporation of 5-Fluorouracil into RNA Affects the Ribonucleolytic Activity of the Exosome Subunit Rrp6

Silverstein, Rebecca A., González de Valdivia, Ernesto, Visa, Neus · 2011 · Molecular Cancer Research
Cited by 53

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

5-Fluorouracil (5FU) is a fluoropyrimidine used for the treatment of solid tumors. 5FU is a precursor of dTTP and UTP during biogenesis, and it interferes with both DNA and RNA metabolism. The RNA exosome, a multisubunit complex with ribonucleolytic activity, has been identified as one of the targets of 5FU in yeast. Studies in human cells have shown that the catalytic subunit of the nuclear exosome, Rrp6, is specifically targeted. Here, we have investigated the direct effect of 5FU on the activity of Rrp6 in Drosophila S2 cells, and we have identified two aspects of Rrp6 function that are altered by 5FU. First, gel filtration analysis revealed that the repertoire of multimolecular complexes that contain Rrp6 is modified by exposure to 5FU, which is consistent with the proposal that incorporation of 5FU into RNA leads to the sequestration of Rrp6 in ribonucleoprotein complexes. Second, the incorporation of 5FU into RNA renders the RNA less susceptible to degradation by Rrp6, as shown by Rrp6 activity assays in vitro. Our results imply that aberrant transcripts synthesized in 5FU-treated cells cannot be turned over efficiently by the surveillance machinery. Together with previous results on the mechanisms of action of 5FU, our findings suggest that the cytotoxicity of 5FU at the RNA level is the result of at least three different effects: the increased levels of retroviral transcripts with mutagenic potential, the reduced synthesis of ribosomes, and the inhibition of the nuclear RNA surveillance pathways. Drugs that reinforce any of these effects may boost the cytotoxicity of 5FU. Mol Cancer Res; 9(3); 332–40. ©2011 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1541-7786.mcr-10-0084

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 27

  1. Ladner, 2001, The role of dUTPase and uracil-DNA repair in cancer chemotherapy, Curr Protein Pept Sci, 2, 361, 10.2174/1389203013380991 · DOI
  2. Doong, 1988, 5-Fluorouracil substitution alters pre-mRNA splicing in vitro, J Biol Chem, 263, 4467, 10.1016/S0021-9258(18)68949-5 · DOI
  3. Patton, 1993, Ribonucleoprotein particle assembly and modification of U2 small nuclear RNA containing 5-fluorouridine, Biochemistry, 32, 8939, 10.1021/bi00085a027 · DOI
  4. Ghoshal, 1994, Specific inhibition of preribosomal RNA processing in extracts from the lymphosarcoma cells treated with 5-fluorouracil, Cancer Res, 54, 632
  5. Hoskins, 2008, RNA-based 5-fluorouracil toxicity requires the pseudouridylation activity of Cbf5p, Genetics, 179, 323, 10.1534/genetics.107.082727 · DOI
  6. Scherf, 2000, A gene expression database for the molecular pharmacology of cancer, Nat Genet, 24, 236, 10.1038/73439 · DOI · Paper page
  7. Lum, 2004, Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes, Cell, 116, 121, 10.1016/S0092-8674(03)01035-3 · DOI · Paper page
  8. Schilders, 2006, Cell and molecular biology of the exosome: how to make or break an RNA, Int Rev Cytol, 251, 159, 10.1016/S0074-7696(06)51005-8 · DOI
  9. Houseley, 2006, RNA-quality control by the exosome, Nat Rev Mol Cell Biol, 7, 529, 10.1038/nrm1964 · DOI · Paper page
  10. Schmid, 2008, Quality control of mRNP in the nucleus, Chromosoma, 117, 419, 10.1007/s00412-008-0166-4 · DOI
  11. Lebreton, 2008, Exosome-mediated quality control: substrate recruitment and molecular activity, Biochim Biophys Acta, 1779, 558, 10.1016/j.bbagrm.2008.02.003 · DOI
  12. Schmid, 2008, The exosome: a multipurpose RNA-decay machine, Trends Biochem Sci, 33, 501, 10.1016/j.tibs.2008.07.003 · DOI · Paper page
  13. Lorentzen, 2008, Structural organization of the RNA-degrading exosome, Curr Opin Struct Biol, 18, 709, 10.1016/j.sbi.2008.10.004 · DOI
  14. Andrulis, 2002, The RNA processing exosome is linked to elongating RNA polymerase II in Drosophila, Nature, 420, 837, 10.1038/nature01181 · DOI · Paper page
  15. Graham, 2009, Core exosome-independent roles for Rrp6 in cell cycle progression, Mol Biol Cell, 20, 2242, 10.1091/mbc.e08-08-0825 · DOI
  16. Kammler, 2008, The RNA exosome component hRrp6 is a target for 5-fluorouracil in human cells, Mol Cancer Res, 6, 990, 10.1158/1541-7786.MCR-07-2217 · DOI
  17. Hessle, 2009, The exosome associates cotranscriptionally with the nascent pre-mRNP through interactions with heterogeneous nuclear ribonucleoproteins, Mol Biol Cell, 20, 3459, 10.1091/mbc.e09-01-0079 · DOI
  18. Graham, 2006, Differential distribution of exosome subunits at the nuclear lamina and in cytoplasmic foci, Mol Biol Cell, 17, 1399, 10.1091/mbc.e05-08-0805 · DOI · Paper page
  19. Synowsky, 2009, Comparative multiplexed mass spectrometric analyses of endogenously expressed yeast nuclear and cytoplasmic exosomes, J Mol Biol, 1300, 10.1016/j.jmb.2008.11.011 · DOI
  20. Callahan, 2010, TRAMP complex enhances RNA degradation by the nuclear exosome component Rrp6, J Biol Chem, 3540, 10.1074/jbc.M109.058396 · DOI · Paper page
  21. Graham, 2009, Interdependent nucleocytoplasmic trafficking and interactions of Dis3 with Rrp6, the core exosome, and importin-alpha3, Traffic, 10, 499, 10.1111/j.1600-0854.2009.00888.x · DOI
  22. Dziembowski, 2007, A single subunit, Dis3, is essentially responsible for yeast exosome core activity, Nat Struct Mol Biol, 14, 15, 10.1038/nsmb1184 · DOI · Paper page
  23. Fang, 2004, 5-fluorouracil enhances exosome-dependent accumulation of polyadenylated rRNAs, Mol Cell Biol, 24, 10766, 10.1128/MCB.24.24.10766-10776.2004 · DOI · Paper page
  24. Chow, 2007, Expanding the nucleotide repertoire of the ribosome with post-transcriptional modifications, ACS Chem Biol, 2, 610, 10.1021/cb7001494 · DOI
  25. Goyle, 2005, Chemotherapy for colorectal cancer, Dig Surg, 22, 401, 10.1159/000091441 · DOI
  26. Greenhalgh, 1989, Effects of 5-fluorouracil on cytotoxicity and RNA metabolism in human colonic carcinoma cells, Cancer Chemother Pharmacol, 25, 37, 10.1007/BF00694336 · doi:10.1007/bf00694336
  27. Schulz, 2006, Methylation of endogenous human retroelements in health and disease, Curr Top Microbiol Immunol, 310, 211

Cited by

See all 53

Metadata

Authors
Silverstein, R. A., González de Valdivia, E., & Visa, N.
Affiliations
Authors' Affiliation: Department of Molecular Biology & Functional Genomics, Stockholm University, Stockholm, Sweden
Venue
Molecular Cancer Research
Published
2011-03-15
Volume
9
Issue
3
Pages
332-340
ISSN
  • 1541-7786
  • 1557-3125
Cited by
53
References
3
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Incorporation of 5-Fluorouracil into RNA Affects the Ribonucleolytic Activity of the Exosome Subunit Rrp6. https://app.cochat.ai/papers/10.1158/1541-7786.mcr-10-0084
The paper
Silverstein, R. A., González de Valdivia, E., & Visa, N. (2011). The Incorporation of 5-Fluorouracil into RNA Affects the Ribonucleolytic Activity of the Exosome Subunit Rrp6. Molecular Cancer Research. https://doi.org/10.1158/1541-7786.mcr-10-0084

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.